The global GLP-1 agonists weight loss drugs market size was estimated at USD 13.84 billion in 2024 and is projected to reach USD 48.84 billion by 2030, growing at a CAGR of 18.54% from 2025 to 2030. The rapid expansion of this market is largely fueled by the increasing prevalence of obesity worldwide, heightened public awareness about health and wellness, and the proven clinical...